Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
17603 | 527 | 34.1 | 57% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2508 | 3401 | 2 METHOXYESTRADIOL//INDOLE 3 CARBINOL//3 3 DIINDOLYLMETHANE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | AMPHIREGULIN AREG | Author keyword | 1 | 50% | 0% | 2 |
2 | IDOXIFENE | Author keyword | 1 | 20% | 1% | 4 |
3 | DIGEST CARDIOVASC MED | Address | 1 | 12% | 1% | 7 |
4 | ANAT STRUCT SCI | Address | 1 | 16% | 1% | 4 |
5 | ADENOMATOUS HYPERPLASTIC NODULE | Author keyword | 1 | 50% | 0% | 1 |
6 | AFFILIATED HAIAN HOSP | Address | 1 | 50% | 0% | 1 |
7 | CANC MINAMI KU | Address | 1 | 50% | 0% | 1 |
8 | CHRONIC HBSAG CARRIERS | Author keyword | 1 | 50% | 0% | 1 |
9 | DIAMINOFLUORESCEIN 2 | Author keyword | 1 | 50% | 0% | 1 |
10 | ESTRADIOL SULFAMATE | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SURROUNDING LIVER | 9 | 48% | 2% | 13 |
2 | ADJACENT LIVER TISSUE | 4 | 67% | 1% | 4 |
3 | VARIANT ESTROGEN RECEPTORS | 4 | 67% | 1% | 4 |
4 | GENDER DISPARITY | 3 | 29% | 2% | 9 |
5 | DEPENDENT HEPATOCARCINOGENESIS | 2 | 67% | 0% | 2 |
6 | SEX HORMONE IMBALANCE | 2 | 67% | 0% | 2 |
7 | CYCLE RELATED KINASE | 2 | 50% | 1% | 3 |
8 | IDOXIFENE | 2 | 36% | 1% | 4 |
9 | HORMONE DEPENDENCY | 1 | 100% | 0% | 2 |
10 | UEBP | 1 | 100% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Role of sex steroid receptors in pathobiology of hepatocellular carcinoma | 2008 | 48 | 145 | 44% |
Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis | 2014 | 5 | 132 | 25% |
Cellular and molecular mechanisms involved in hepatocellular carcinoma gender disparity | 2010 | 26 | 52 | 37% |
Role of estrogen in hepatocellular carcinoma: is inflammation the key? | 2014 | 4 | 107 | 25% |
Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver | 2014 | 16 | 97 | 8% |
Progesterone and Related Compounds in Hepatocellular Carcinoma: Basic and Clinical Aspects | 2013 | 5 | 89 | 21% |
Endocrine treatment of hepatocellular carcinoma. Any evidence of benefit? | 1998 | 17 | 53 | 51% |
HEPATIC-METABOLISM AND CARCINOGENESIS - ITS ROLE IN HEPATOMA AND ADENOCARCINOMA | 1988 | 15 | 7 | 71% |
Estrogen derivatives: novel therapeutic agents for liver cirrhosis and portal hypertension | 2013 | 3 | 97 | 18% |
ESTROGEN AND ANDROGEN RECEPTORS IN LIVER - THEIR ROLE IN LIVER-DISEASE AND REGENERATION | 1985 | 68 | 41 | 41% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DIGEST CARDIOVASC MED | 1 | 12% | 1.3% | 7 |
2 | ANAT STRUCT SCI | 1 | 16% | 0.8% | 4 |
3 | AFFILIATED HAIAN HOSP | 1 | 50% | 0.2% | 1 |
4 | CANC MINAMI KU | 1 | 50% | 0.2% | 1 |
5 | FIRC LIVER CANC UNIT | 1 | 50% | 0.2% | 1 |
6 | HEPATO PANCREATICO BILIARY SURG | 1 | 50% | 0.2% | 1 |
7 | M ASCOLI CANC HOSP | 1 | 29% | 0.4% | 2 |
8 | 21 CENTURY COE | 0 | 33% | 0.2% | 1 |
9 | ALCOHOL PROJECT | 0 | 33% | 0.2% | 1 |
10 | ANUS INTESTINE | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000120726 | DRUGS ABUSE//REPRODUCTIVE EFFECTS OF AODU ALCOHOL AND OTHER DRUG USE//STRUCT CELL BIOL PROGRAM |
2 | 0.0000106416 | CHIRURG D//ALCOHOLIC LIVER DISEASE ALD//CHRONIC HEPATITIS INDUCED BY ALCOHOL |
3 | 0.0000096034 | SPECIFIC BINDING SITES//BILE ACID PRODUCTION//CHRONIC AND ACUTE TREATMENTS |
4 | 0.0000084693 | MEDIUM TERM BIOASSAY//INITIATION ASSAY//HEPATIC PRENEOPLASIA |
5 | 0.0000074560 | CORNCOB BEDDING//TYPE II SITES//TYPE II ESTROGEN BINDING SITES |
6 | 0.0000073228 | DEVELOPING COMMUNITY//ALPHAFOETOPROTEIN//19 |
7 | 0.0000066990 | JIANGDA PATHOL//APOPTOTIC EFFECTS//BETA CX |
8 | 0.0000063561 | FOCAL NODULAR HYPERPLASIA//HEPATOCELLULAR ADENOMA//HEPATIC ADENOMA |
9 | 0.0000058886 | HEPATOCELLULAR CARCINOMA//TRANSARTERIAL CHEMOEMBOLIZATION//MIRIPLATIN |
10 | 0.0000054894 | DEPURINATING ESTROGEN DNA ADDUCTS//INDENESTROL A//CATECHOL ESTROGENS |